Company / Current Assets per Share
Intellia Therapeutics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5.17
FY2025
5-year range
$5.17 / $16.34
FY2021-FY2025
Trend
-24.8%
vs FY2024
Sector context
#131 of 163
Health Care
What the data says
Intellia Therapeutics, Inc.'s current assets per share of $5.17 is lower than 80% of companies in the Health Care sector (FY2025). Current Assets per Share has declined for 3 consecutive years, from $16.34 in FY2022 to $5.17 in FY2025.
Based on SEC 10-K filings.
5.17 in FY2025 with a 5-year CAGR of -15.9%.
Declined from $11.46 to $5.17 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -31.8%
- 5-Year CAGR
- -15.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 163This company $5.17 Sector average $52.97
▼
-90.2% below sector average
Key checks
Key Insights
- Intellia Therapeutics, Inc.'s current assets per share has declined for 3 consecutive years.
- In FY2025, current assets per share decreased 24.8% year-over-year.
- Ranks #131 out of 163 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.17 | -24.8% |
| FY2024 | $6.88 | -40.0% |
| FY2023 | $11.46 | -29.8% |
| FY2022 | $16.34 | +40.6% |
| FY2021 | $11.61 | -5.4% |
| FY2020 | $12.28 | +91.9% |
| FY2019 | $6.40 | -16.5% |
| FY2018 | $7.67 | -22.2% |
| FY2017 | $9.85 | -22.2% |
| FY2016 | $12.66 | -96.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026